DARE — Dare Bioscience, Inc.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1401914 ·
Last close
$0.43
Market Cap
$8.44M
52W High
$3.78
52W Low
$0.41
ADV30
162,496
Next earnings
2026-11-16

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 47,628 -132,851 -3,092,145 -3,157,936 22,098,552 11,531,684 19,757,177
Jun 2026 187,546 -132,343 -2,967,980 -2,982,773 22,370,109 12,617,594 22,930,209
Mar 2026 152,455 -89,870 -2,998,898 -2,999,889 27,828,414 18,519,784 27,093,963
Dec 2025 1,023,676 727,877 -1,471,268 -1,441,718 32,474,563 24,711,356 29,631,929

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-11,293,561
Investing CF
$-461,929
Financing CF
$19,310,108
CapEx
$-538,674
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.14
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-194,671,566
Inventory
—
Receivables
$456,429
ST Investments
—
EBIT TTM
$-11,110,294
Pretax Income TTM
$-10,987,146
Interest Exp TTM
—
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,365,939
EBITDA
$-8,978,829
Free Cash Flow
$-6,908,168
Enterprise Value
$4,941,179
Total Cash
$12,617,594
Total Debt
$6,763,626
Shares Out
19,669,083
Trailing EPS
$-0.66
Book Value
$-0.04
ROE
—
ROA
-39.3%
Div Yield
—

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 1,030,193 -13,552,334 -13,399,274 32,474,563 29,631,929 2,842,634 -9,885,870
Dec 2024 9,784 -23,451,485 -4,053,599 22,101,131 28,113,220 -6,012,089 5,473,555
Dec 2023 2,807,885 -30,939,880 -30,161,391 21,282,215 26,329,855 -5,047,640 -38,856,654
Dec 2022 10,000,000 -31,385,488 -30,947,738 43,826,383 32,714,273 11,112,110 -18,088,429

TTM Snapshot

Revenues TTM
$1,365,939
NetIncome TTM
$-10,987,146
OpCashFlow TTM
—
Assets (Latest)
$22,370,109
Forward EPS
$-0.41

Peers — same industry

TickerNameMarket CapLastDaily %
CALC CalciMedica, Inc. $8.41M $1.22 —
VTGN Vistagen Therapeutics, Inc. $8.34M $0.19 —
PHIO Phio Pharmaceuticals Corp. $8.57M $0.72 —
KYNB KYNTRA BIO, INC. $8.26M $2.04 —
MTVA MetaVia Inc. $8.24M $1.25 —

News headlines (Yahoo Finance, 1h cache)

Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Misses Revenue Estimates
2026-11-16 21:15 · Yahoo
Daré Bioscience Receives Approximately $852,000 in Additional Grant Funding
2026-11-16 14:09 · Yahoo
Daré Bioscience to Host Third Quarter 2026 Financial Results and Company Update Conference Call and Webcast on November 16, 2026
2026-11-10 14:00 · Yahoo
Daré Bioscience Releases Next Episode in “CEO Corner” Video Series
2026-11-09 14:01 · Yahoo
Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
2026-11-04 14:05 · Yahoo
Daré Bioscience Surpasses $43 Million in Non-Dilutive Grant Funding as Investigational Programmable Drug Delivery Platform Gains Momentum
2026-10-30 12:32 · Yahoo
Daré Bioscience to Showcase Its Investigational Programmable Device, DARE-IDDS, at PODD 2026: One Device, Designed to Deliver 100+ Doses and to be Controlled Wirelessly
2026-10-26 12:32 · Yahoo
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
2026-10-19 12:56 · Yahoo
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
2026-10-13 13:15 · Yahoo
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
2026-10-08 13:15 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.